Article Information
History
- August 26, 2020.
Article Versions
- Version 1 (July 2, 2020 - 03:43).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jason Rosado1,2,
- Michael T. White1,
- Rhea J. Longley3,4,
- Marcus Lacerda5,6,
- Wuelton Monteiro6,
- Jessica Brewster3,
- Jetsumon Sattabongkot7,
- Mitchel Guzman-Guzman9,
- Alejandro Llanos-Cuentas8,
- Joseph M. Vinetz8,9,10,11,
- Dionicia Gamboa9,11 and
- Ivo Mueller1,3,4,*
- 1Unit of Malaria: Parasites and hosts, Institut Pasteur, Paris, France
- 2Sorbonne Université, ED 393, F-75005 Paris, France
- 3Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
- 4Department of Medical Biology, University or Melbourne, Australia
- 5Instituto Leônidas & Maria Deane (Fiocruz), Manaus, Brazil
- 6Tropical Medicine Foundation Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil
- 7Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
- 8Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
- 9Laboratorio ICEMR-Amazonia, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru
- 10Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
- 11Departamento de Ciencias Celulares y Moleculares, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru
- ↵*Correspondence
E-mail: mueller{at}wehi.edu.au (I.M)
Posted August 26, 2020.
Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts
